X
Xeris Biopharma Holdings, Inc. (XERS)
NMS – Real vaqt narxi. Valyuta: USD
6.26
+0.12 (1.95%)
Yopilishda: May 12, 2026, 4:00 PM EDT
6.35
+0.09 (1.44%)
Bozor oldidan: May 13, 2026, 6:46 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
6.26
+0.12 (1.95%)
Yopilishda: May 12, 2026, 4:00 PM EDT
6.35
+0.09 (1.44%)
Bozor oldidan: May 13, 2026, 6:46 AM EDT
This stock has a consensus price target of $9.28 based on the ratings of 9 analysts. The high is $18.00 and the low is $4.50.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 4.5 | $ 9.28 | $ 18 |
| O’zgarish | -26.71% | 51.14% | 193.16% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-02 | 62.87% | HC Wainwright & Co. | $10 → $10 | Reiterates | Buy |
| 2026-01-09 | 62.87% | HC Wainwright & Co. | $10 → $10 | Reiterates | Buy |
| 2025-12-09 | 46.58% | Barclays | $9 | Initiates Coverage On | Overweight |
| 2025-11-07 | 193.16% | Oppenheimer | $18 → $18 | Maintains | Outperform |
| 2025-11-07 | 62.87% | HC Wainwright & Co. | $10 → $10 | Maintains | Buy |